<DOC>
	<DOC>NCT02512510</DOC>
	<brief_summary>The purpose of this study is to measure the effectiveness and safety of TD 4208, an investigational drug being developed to treat people with moderate to very severe COPD, compared to placebo, a treatment without activity.</brief_summary>
	<brief_title>Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Subject is a male or female subject 40 years of age or older Females who are pregnant, lactating, breastfeeding or planning to become pregnant during the study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease, COPD</keyword>
</DOC>